Inclusion completed

A randomised Phase II study of MK-3475 versus Chemotherapy in Pateients with Advanced Melanoma

Cancer type: Melanoma

Phase: II

Principal Investigator: Nyakas Martha

Country: NO

Keywords: Norway, Oslo, Jelanoma, MSD, MK-3475-002

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01704287?term=MK-3475-002&rank=1